Chief Executive Officer/President
Mary E. Dixon is the Chief Executive Officer and President of Improvita, Inc., a company dedicated to advancing patient-centered design and usability in regulated healthcare technologies. With more than three decades of experience in the pharmaceutical and life sciences industries, Mary brings a unique perspective that blends scientific expertise, regulatory strategy, and product development leadership.
Mary founded Improvita to address a growing need in healthcare innovation: ensuring that complex medical technologies are not only effective but also intuitive and safe for real-world users. Leveraging a passion for innovation, Improvita specializes in rigorous human factors engineering assessments and usability testing to ensure product effectiveness and regulatory compliance. Through consultancy services, the company guides clients through regulatory processes, ultimately improving patient outcomes and user satisfaction.
Mary’s vision for Improvita centers on one core belief: healthcare innovation must be designed with the end user in mind. By combining human factors science with regulatory expertise, she continues to help life science companies deliver technologies that truly improve patient care.
Chair of the Board
As Chair of the Board of Improvita, Mary E. Dixon works closely with board members and leadership teams to ensure the company maintains its commitment to innovation, regulatory excellence, and human-centered design.
Mary’s governance approach emphasizes transparency, ethical leadership, and long-term value creation. By fostering strong partnerships and maintaining rigorous standards for usability science and regulatory compliance, she ensures Improvita continues to help healthcare innovators develop products that are both effective and user-focused.
Her leadership continues to shape Improvita’s growth as a trusted partner for organizations developing the next generation of medical devices and digital health technologies.
